180 related articles for article (PubMed ID: 36300779)
41. [Basic and clinical studies of the gene product-targeting therapy based on leukemogenesis--editorial].
Chen SJ; Chen LJ; Zhou GB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Feb; 13(1):1-8. PubMed ID: 15748426
[TBL] [Abstract][Full Text] [Related]
42. Successful treatment of acute promyelocytic leukemia with a t(X;17)(p11.4;q21) and BCOR-RARA fusion gene.
Ichikawa S; Ichikawa S; Ishikawa I; Takahashi T; Fujiwara T; Harigae H
Cancer Genet; 2015 Apr; 208(4):162-3. PubMed ID: 25790901
[No Abstract] [Full Text] [Related]
43. Pathogenesis and management of acute promyelocytic leukemia.
Warrell RP
Annu Rev Med; 1996; 47():555-65. PubMed ID: 8712802
[TBL] [Abstract][Full Text] [Related]
44. Differentiation therapy of acute promyelocytic leukemia: clinical and molecular features.
Miller WH
Cancer Invest; 1996; 14(2):142-50. PubMed ID: 8597899
[No Abstract] [Full Text] [Related]
45. IRF2BP2-RARA t(1;17)(q42.3;q21.2) APL blasts differentiate in response to all-trans retinoic acid.
Mazharuddin S; Chattopadhyay A; Levy MY; Redner RL
Leuk Lymphoma; 2018 Sep; 59(9):2246-2249. PubMed ID: 29350080
[No Abstract] [Full Text] [Related]
46. Retinoic acid receptors: involvement in acute promyelocytic leukemia.
Agadir A; Cornic M; Gourmel B; Lefebvre P; Degos L; Chomienne C
Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):263-74. PubMed ID: 7920173
[TBL] [Abstract][Full Text] [Related]
47. Acute promyelocytic leukemia: from genetics to treatment.
Grignani F; Fagioli M; Alcalay M; Longo L; Pandolfi PP; Donti E; Biondi A; Lo Coco F; Grignani F; Pelicci PG
Blood; 1994 Jan; 83(1):10-25. PubMed ID: 8274729
[No Abstract] [Full Text] [Related]
48. Characterisation of the PML/RAR alpha rearrangement associated with t(15;17) acute promyelocytic leukaemia.
Grimwade D; Solomon E
Curr Top Microbiol Immunol; 1997; 220():81-112. PubMed ID: 9103677
[TBL] [Abstract][Full Text] [Related]
49. Acute promyelocytic leukemia: new issues on pathogenesis and treatment response.
Vitoux D; Nasr R; de The H
Int J Biochem Cell Biol; 2007; 39(6):1063-70. PubMed ID: 17468032
[TBL] [Abstract][Full Text] [Related]
50. All trans retinoic acid as a targeting drug for differentiation therapy in acute promyelocytic leukemia.
Degos L
Cancer Treat Res; 1993; 64():1-13. PubMed ID: 8095789
[No Abstract] [Full Text] [Related]
51. Acute promyelocytic leukemia following aleukemic leukemia cutis harboring NPM/RARA fusion gene.
Otsubo K; Horie S; Nomura K; Miyawaki T; Abe A; Kanegane H
Pediatr Blood Cancer; 2012 Nov; 59(5):959-60. PubMed ID: 22573339
[No Abstract] [Full Text] [Related]
52. Acute promyelocytic leukemia relapsing as secondary acute myelogenous leukemia with translocation t(3;21)(q26;q22) and RUNX1-MDS1-EVI1 fusion transcript.
Park TS; Choi JR; Yoon SH; Song J; Kim J; Kim SJ; Kwon O; Min YH
Cancer Genet Cytogenet; 2008 Dec; 187(2):61-73. PubMed ID: 19027486
[TBL] [Abstract][Full Text] [Related]
53. Translocations of the RARalpha gene in acute promyelocytic leukemia.
Zelent A; Guidez F; Melnick A; Waxman S; Licht JD
Oncogene; 2001 Oct; 20(49):7186-203. PubMed ID: 11704847
[TBL] [Abstract][Full Text] [Related]
54. Overexpression of wild-type retinoic acid receptor alpha (RARalpha) recapitulates retinoic acid-sensitive transformation of primary myeloid progenitors by acute promyelocytic leukemia RARalpha-fusion genes.
Du C; Redner RL; Cooke MP; Lavau C
Blood; 1999 Jul; 94(2):793-802. PubMed ID: 10397747
[TBL] [Abstract][Full Text] [Related]
55. TBLR1 fuses to retinoid acid receptor α in a variant t(3;17)(q26;q21) translocation of acute promyelocytic leukemia.
Chen Y; Li S; Zhou C; Li C; Ru K; Rao Q; Xing H; Tian Z; Tang K; Mi Y; Wang B; Wang M; Wang J
Blood; 2014 Aug; 124(6):936-45. PubMed ID: 24782508
[TBL] [Abstract][Full Text] [Related]
56. [All-trans-retinoic acid in the treatment of promyelocytic leukemia].
Nousiainen T; Jantunen E
Duodecim; 1993; 109(16):1410-4. PubMed ID: 7720600
[No Abstract] [Full Text] [Related]
57. A retinoid-resistant acute promyelocytic leukemia subclone expresses a dominant negative PML-RAR alpha mutation.
Shao W; Benedetti L; Lamph WW; Nervi C; Miller WH
Blood; 1997 Jun; 89(12):4282-9. PubMed ID: 9192750
[TBL] [Abstract][Full Text] [Related]
58. [Acute promyelocytic leukemia: model of differential therapy].
Samochatova EV; Rumiantsev AG
Gematol Transfuziol; 1996; 41(2):29-32. PubMed ID: 8754158
[No Abstract] [Full Text] [Related]
59. All-trans-retinoic acid in acute promyelocytic leukemia.
Sanz MA; Martín G; Díaz-Mediavilla J
N Engl J Med; 1998 Feb; 338(6):393-4. PubMed ID: 9454087
[No Abstract] [Full Text] [Related]
60. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid).
Warrell RP; Frankel SR; Miller WH; Scheinberg DA; Itri LM; Hittelman WN; Vyas R; Andreeff M; Tafuri A; Jakubowski A
N Engl J Med; 1991 May; 324(20):1385-93. PubMed ID: 1850498
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]